A new study put Eli Lilly's Zepbound and Novo Nordisk's Wegovy to the test. Here's which one will help you lose more weight.
Novo says that it has regulatory clearance to buy three key manufacturing sites used to make drugs like Wegovy, its ...
The world’s largest food and beverage company said it plans to launch a frozen food brand that will cater to consumers who ...
Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound and other anti-obesity drugs was third-highest in the ...
Patients taking the drugs eat less and they can experience side effects such as nausea, so they should prioritize certain ...
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy ...
Maryland’s Medicaid program now offers partial coverage of popular obesity drugs, with the state spending more than $68 ...
Over 18 months, people taking Zepbound lost more weight on average than those on Wegovy, according to the first head-to-head ...
Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...
Patients using weight loss drugs in the UK have overwhelmingly opted for Mounjaro over Wegovy in the last six months, ...